Press Releases

RSS
  • Feb 11, 2016
    ENGLEWOOD, Colo., Feb. 11, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the Company will present its operational results for the second fiscal quarter of 2016 on Tuesday, February 16, 2016, at 4:30 p.m. ET.  The Company will review recent accomplishments and pr...
    Feb 9, 2016
    ENGLEWOOD, Colo., Feb. 9, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on commercializing treatments for urological conditions, today announced the first commercial sales of its MiOXSYS™ System in Europe and the Middle East.  MiOXSYS is the company's in vitro diagnostic platform for assessing the level of oxidative stress in s...
    Feb 3, 2016
    ENGLEWOOD, Colo., Feb. 3, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference, taking place in New York on February 10-11, 2016....
    Jan 27, 2016
    ENGLEWOOD, Co., Jan. 27, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today announced that Josh Disbrow, Aytu's Chief Executive Officer, and Jarrett Disbrow, Aytu's Chief Operating Officer, have been added to the Aytu Board of Directors. The two will join Michael Macaluso, who r...
    Jan 12, 2016
    ENGLEWOOD, Colo., Jan. 12, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty healthcare company focused on commercializing treatments for urological and related conditions, today announced that it has obtained CE Marking in Europe for its MiOXSYS™ System.  MiOXSYS is the company's in vitro diagnostic platform for assessing the level of oxidative stress in semen as an aid in...
    Jan 6, 2016
    ENGLEWOOD, Colo., Jan. 6, 2016 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, announced today that the Company will present at the Biotech Showcase™ 2016, taking place in San Francisco, CA, on January 11–13, 2016....
    Dec 14, 2015
    ENGLEWOOD, Colo., Dec. 14, 2015 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, today announced it has qualified and is now trading on the OTCQX® Best Market, operated by OTC Markets Group. ...
    Dec 14, 2015
    NEW YORK, Dec. 14, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial markets, today announced Aytu BioScience, Inc. (OTCQX: AYTU), a commercial-stage specialty healthcare company focused on the $10 billion urology market, has qualified to trade on the OTCQX® Best Market.  ...
    Dec 7, 2015
    Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...
    Nov 30, 2015
    ENGLEWOOD, Colo., Nov. 30, 2015 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQB: AYTU), a commercial-stage specialty healthcare company focused on urological and related conditions, will present at two upcoming investor conferences. Aytu is scheduled to present live at VirtualInvestorConferences.com, an interactive real-time virtual conference, to be held December 3, 2015, and at LD Micro's Main Eve...